The company continues to execute its proven growth strategy which consists of three pillars: high-impact innovation, trusted partner status with customers, and enhancing commercial capabilities, including expansion of geographic sales reach and e-commerce platforms. The company's references to productivity improvements generally refer to improved cost efficiencies from its practical process improvement (PPI) business system, including reduced costs resulting from implementing continuous improvement methodologies, global sourcing initiatives, and a lower cost structure following restructuring actions. The company has played a meaningful role in the production of COVID-19 vaccines and therapies, demonstrating its capability to adapt and respond to market dynamics and customer needs. The acquisition of the Binding Site Group and Corevitas, LLC expands the segment's portfolio with pioneering innovation in diagnostics and monitoring, enhancing decision-making and the time and cost of drug development. The company's strategic growth investments target enhancements in operational infrastructure and research and development projects to improve customer experience. The company believes that its existing cash and cash equivalents and future cash flow from operations, together with available borrowing capacity, will be sufficient to meet the cash requirements of its existing businesses for the foreseeable future. The company uses non-GAAP financial measures to provide a better understanding of its core operating results and future prospects, which are essential for evaluating operational performance and making strategic decisions. The company assesses income tax positions and records tax benefits based on management's evaluation of the facts, circumstances, and information available at the reporting date, indicating a robust approach to resource management and operational efficiency. The company's ability to mobilize and deploy IT-based resources in combination with leveraging other resources and capabilities has become a key factor in transforming it into a competitive force. The company’s IT capabilities represent the application of technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals. The company evaluates segment operating performance using operating income before certain charges/credits, reflecting a focus on strategic resource allocation and operational effectiveness. The company’s investments in technology infrastructure and digital transformation initiatives are aimed at enhancing its operational flexibility and market agility, which are critical in responding to environmental opportunities and challenges. The company’s strategic management practices include continuous monitoring and evaluation systems to ensure alignment with organizational goals and market responsiveness. The company’s operational activities are supported by strong productivity improvements and pricing realization, which address higher inflation and enhance overall performance metrics. The company’s commitment to enhancing its IT architecture and governance frameworks is evident in its ongoing investments in technology capabilities, which are essential for maintaining competitive advantage and driving business innovation.